Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FDG PET/CT for TMJ Synovitis Diagnosis
NCT01471418Phase 2Withdrawn
- Sponsor
- University of Pennsylvania
- Start
- Dec 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fludeoxyglucose f 18 in temporomandibular joint disorders (TMD), sponsored by University of Pennsylvania. Planned start Dec 2011; status: withdrawn.
02
Drugs
fludeoxyglucose f 18
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT01471418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471418.